Original language | Undefined/Unknown |
---|---|
Journal | Journal of Clinical Oncology |
Publication status | Published - 2023 |
IMMULAB: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early-stage hepatocellular carcinoma (HCC)
Arndt Vogel, Oliver Waidmann, Tobias Muller, Gabriele Margareta Siegler, Thorsten Oliver Goetze, Enrico N. De Toni, Maria A. Gonzalez-Carmona, Guido Hausner, Michael Geissler, Ludwig Fischer von Weikersthal, Angelika M. R. Kestler, Fabian Finkelmeier, Matthias Kleiss, Jens U. Marquardt, Andreas Teufel, Jorge Klagges, Regina Eickhoff, Salah-Eddin Al-Batran, Anna Lena Saborowski
Research output: Contribution to journal › Original Article › peer-review
4
Citations
(Web of Science)